Health Atlas
Menu
Evidence-led reference

Supplements

Passionflower: medicinal plant parts, tea versus extracts, subjective versus measured sleep, a small anxiety comparison, traditional use, and sedation risks

7 sources · Latest source check 2026-10-13 UTC
On this page

Passionflower evidence for sleep or anxiety is limited and preparation-specific. Small studies suggest possible benefits on some measures, but do not establish every claim or equivalence to standard treatment. The medicinal plant discussed here is Passiflora incarnata; a botanical name, route and preparation are needed before comparing products.[1]

Plant, preparation and measurement are different concepts

Plant, preparation and measurement are different concepts
TermMeaning
Passiflorae herbaAbove-ground parts of Passiflora incarnata.[5]
Tea versus extractDifferent preparations used in separate studies.[1]
Sleep diaryA participant’s recorded experience of sleep.[2]
Polysomnography / PSGOvernight physiological sleep measurement.[3]

The tea study used a repeated-measures comparison

Ngan and Conduit’s 2011 double-blind study involved 41 adults aged eighteen to thirty-five. Each participant received passionflower tea and placebo tea in a counterbalanced order, with a one-week washout between treatment periods. Each period lasted a week, with sleep diaries completed throughout. Ten participants also underwent overnight polysomnography.[2]

The main positive result was subjective sleep quality

Of six diary measures analyzed, sleep quality was rated significantly better with passionflower. That finding concerns a participant-reported outcome in healthy adults with mild sleep-quality fluctuations. It is different from demonstrating treatment of a diagnosed insomnia disorder, objective improvement in all sleep measurements or a lasting effect.[2]

A small PSG subgroup is not the full study population

Only ten of the 41 underwent overnight physiological measurement. The original full abstract was inspected, but complete endpoint multiplicity, PSG results, sponsor role and later replication remain to be appraised. The small short comparison cannot determine every tea or extract’s effect.[2]

Total sleep time differed, while some other endpoints did not

The reported total-sleep-time change favored extract over placebo, with P=0.049. Sleep efficiency and wake after sleep onset improved within the extract group, but did not differ significantly from placebo. Quoting those within-group changes as demonstrated treatment superiority would overstate what the comparison established.[3]

Two-week findings do not establish sustained insomnia control

The original full abstract was inspected. Complete clinical-significance, multiple-endpoint, missing-data, safety and sponsor-role appraisal remains pending. A favorable measured endpoint does not demonstrate that symptoms stay improved over months or identify an individual treatment choice.[3]

The anxiety pilot compared two active interventions

Akhondzadeh and colleagues’ 2001 pilot randomized 36 outpatients with generalized anxiety disorder to passionflower extract or oxazepam for four weeks. Each group received a matching placebo for the other formulation, supporting blinding. There was no group receiving only inert placebos. The study therefore used an active comparator rather than a placebo-only efficacy comparison.[4]

No significant difference does not prove equal effectiveness

The investigators reported no significant between-protocol difference at the end of the trial. In a small pilot, that does not establish equivalence or noninferiority within a clinically acceptable margin. Both groups improving does not independently show that the extract exceeds a placebo-only intervention. The authors called for a larger trial.[4]

EMA describes a traditional-use basis for specified purposes

EMA’s public summary describes specified passionflower preparations for mild mental-stress symptoms and aiding sleep on the basis of traditional use. It explicitly notes insufficient clinical-trial evidence for firm conclusions. This medicinal category includes a history of use and plausible effectiveness; it is not the same claim as strong proof from modern randomized comparisons.[5]

The summary does not cover every combination product

EMA’s explanation excludes combinations with other herbs from that particular assessment. It describes age-specific use and a separate periodic-review call in 2025. The indexed original public summary and catalog were inspected; complete assessment, subsequent review outcome and individual national product labeling remain to be reconciled.[5]

Sedation and reproductive concerns remain relevant

NCCIH lists drowsiness, dizziness and confusion, and describes potential additive effects with anesthetic or other sedating medicines. Pregnancy use is a concern because of possible uterine contractions; breastfeeding information is limited. A short trial’s tolerability cannot establish an individual medicine combination or eliminate procedure-related risks.[1]

Short-term procedural anxiety is another distinct question

A placebo-controlled trial randomized sixty patients to a defined oral Passiflora preparation or placebo before outpatient surgery. The authors reported lower anxiety without detected sedation under those conditions. This is a specific premedication setting with clinical monitoring, not a study of daily stress, chronic anxiety disorder, insomnia or self-treatment before an operation. A reassuring short-term assessment does not establish absence of rare adverse effects or interactions with all anesthetic regimens.[6]

Evidence & uncertainty

The two-week insomnia trial favored total measured sleep time. Other within-group improvements did not show superiority to placebo. A positive sleep endpoint therefore should not become a claim that every aspect of insomnia improved.[3]

Selected-source overview · Independent review pending

Published questions

Which plant parts does EMA’s Passiflorae herba assessment describe?

Selected-source overview · Independent review pending. Read the evidence context.

Above-ground Passiflora incarnata parts.[5]

Evidence behind this answer
  • Passiflorae herba: passion flower herbal medicinal product

    agency herbal medicine assessment · Date not stated
    Original indexed public-summary/catalog passages inspected; direct retrieval blocked, full assessment and later periodic-review outcome not appraised · Public summary: above-ground parts, traditional-use basis, combination exclusions and 2025 periodic-review catalog

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Did all 41 participants in the tea study undergo polysomnography?

Selected-source overview · Independent review pending. Read the evidence context.

Ten underwent it.[2]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Was the tea study’s significant sleep-quality result a diary rating?

Selected-source overview · Independent review pending. Read the evidence context.

It was participant-reported.[2]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Did the two-week insomnia trial favor total measured sleep time?

Selected-source overview · Independent review pending. Read the evidence context.

Its comparison favored extract.[3]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Did improved sleep efficiency within the passionflower group establish placebo superiority?

Selected-source overview · Independent review pending. Read the evidence context.

The between-group comparison was not significant.[3]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Did the small oxazepam pilot include a placebo-only group?

Selected-source overview · Independent review pending. Read the evidence context.

It compared two active protocols.[4]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does the passionflower pilot’s nonsignificant difference prove equivalence to oxazepam?

Selected-source overview · Independent review pending. Read the evidence context.

It does not establish equivalence.[4]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does passionflower’s botanical origin establish pregnancy safety?

Selected-source overview · Independent review pending. Read the evidence context.

NCCIH describes a uterine-contraction concern.[1]

Evidence behind this answer
  • Passionflower: Usefulness and Safety

    agency condition or prevention explanation · Date not stated
    Selected relevant original official page passages inspected · Preparation-specific uncertain efficacy, sedation, procedure, pregnancy and breastfeeding questions

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does a preoperative passionflower trial establish treatment for everyday anxiety?

Selected-source overview · Independent review pending. Read the evidence context.

No. It tested a specific preparation shortly before outpatient surgery. Chronic anxiety, repeated use and different preparations require their own comparisons.[6]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

What does improvement on a state-anxiety questionnaire mean?

Selected-source overview · Independent review pending. Read the evidence context.

It describes measured anxiety in the immediate study setting. It does not by itself establish long-term functioning, remission of an anxiety disorder, or universal absence of impairment.[7]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

The insomnia trial studied a different population and preparation

Lee and colleagues’ 2020 report described 110 adults meeting DSM-5 insomnia criteria. They received a passionflower extract or placebo for two weeks, with overnight polysomnography and symptom questionnaires. This was a distinct preparation and clinical setting from the young healthy-adult tea study.[3]

A performance finding needs its own limited interpretation

Oxazepam had a faster reported onset and more reported job-performance impairment. That result concerns this short selected comparison; it does not certify passionflower for driving, work or combination with sedatives. Complete assessment, precision and sponsorship appraisal remains pending.[4]

The name alone does not establish trial equivalence

NCCIH describes limited evidence for anxiety and some sleep measures, with insufficient information for several other promoted purposes. A tea, extract and multicomponent sleep product need separate constituent and outcome checks. Results from one cannot establish the effectiveness of every product called “passionflower.”[1]

A second procedural study used anxiety and performance measures

Another randomized study in sixty patients undergoing spinal anesthesia assessed anxiety, sedation and psychomotor performance. The extract suppressed the preoperative increase in the state-anxiety score; other measured comparisons did not show significant differences. STAI is a questionnaire about current anxiety, not a diagnosis or a long-term functional outcome. The similar procedural finding is suggestive in that setting, but differences in preparation and context limit extension to chronic use. Complete adverse-event and sponsor-role appraisal remains pending.[7]

References

  1. Passionflower: Usefulness and Safety

    Agency condition or prevention explanation

    NCCIH · Content/publication date: not stated
    Accessed: 2026-10-09 UTC · Selected relevant original official page passages inspected
    Cited sections: Preparation-specific uncertain efficacy, sedation, procedure, pregnancy and breastfeeding questions

  2. A double-blind, placebo-controlled investigation of the effects of Passiflora incarnata (passionflower) herbal tea on subjective sleep quality

    Randomized repeated measures trial

    Ngan A and Conduit R · Content/publication date: 2011
    Accessed: 2026-10-09 UTC · Original full abstract inspected; complete trial-level appraisal pending
    Cited sections: 2011 full abstract: 41 young adults, one-week periods, ten PSG participants and subjective quality outcome

  3. Effects of Passiflora incarnata Linnaeus on polysomnographic sleep parameters in subjects with insomnia disorder: a double-blind randomized placebo-controlled study

    Randomized trial

    Lee J and colleagues · Content/publication date: 2020
    Accessed: 2026-10-09 UTC · Original full abstract inspected; complete trial-level appraisal pending
    Cited sections: 2020 full abstract: 110 adults, two weeks, TST benefit versus nonsignificant between-group efficiency/WASO comparisons

  4. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam

    Randomized active comparator trial

    Akhondzadeh S and colleagues · Content/publication date: 2001
    Accessed: 2026-10-09 UTC · Original indexed full abstract inspected; direct retrieval blocked, complete trial-level appraisal pending
    Cited sections: 2001 issue: 36 outpatients, four weeks, double-dummy active comparison and no placebo-only arm

  5. Passiflorae herba: passion flower herbal medicinal product

    Agency herbal medicine assessment

    EMA HMPC · Content/publication date: not stated
    Accessed: 2026-10-09 UTC · Original indexed public-summary/catalog passages inspected; direct retrieval blocked, full assessment and later periodic-review outcome not appraised
    Cited sections: Public summary: above-ground parts, traditional-use basis, combination exclusions and 2025 periodic-review catalog

  6. Preoperative oral Passiflora incarnata reduces anxiety in ambulatory surgery patients: a double-blind, placebo-controlled study

    Randomized trial

    Movafegh A and colleagues · Content/publication date: 2008
    Accessed: 2026-10-13 UTC · Original indexed methods/results inspected; direct full-text retrieval unavailable; independent full-text appraisal not completed
    Cited sections: Original indexed methods and conclusion: sixty patients, premedication before surgery

  7. Passiflora incarnata Linneaus as an anxiolytic before spinal anesthesia

    Randomized trial

    Aslanargun P and colleagues · Content/publication date: 2012
    Accessed: 2026-10-13 UTC · Original abstract inspected on Gazi University publication record after direct PubMed retrieval failed; no independent full-text appraisal
    Cited sections: Original abstract on author-institution publication record: sixty patients, STAI and psychomotor outcomes

Scope & review

Population
Readers exploring passionflower; healthy-adult sleep fluctuations, diagnosed insomnia and generalized-anxiety pilot comparisons are distinguished
Exposure or intervention
Defined plant parts, tea or extract, placebo comparisons and a double-dummy active-comparator trial
Comparison
Source-specific symptom, care, screening or comparator settings
Outcomes
Subjective sleep quality, physiological sleep time/efficiency, anxiety scales and sedative/reproductive risks
Timeframe
One-week tea periods, two-week insomnia and four-week anxiety studies, plus a dated agency summary and review call
Jurisdiction
Selected US/UK agency and US/European professional guidance; jurisdiction and eligibility differences are labeled

Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-09 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
  • 2026-10-13 UTC: Added original-study comparisons and practical reader questions while preserving existing anchors; independent expert review remains incomplete.

What this article still leaves open

  • Contemporary synthesis, full trial-level bias/sponsor roles, endpoint multiplicity, clinical significance and the EMA periodic-review outcome remain outstanding.
  • Product chemistry, procedural contexts, dependence, combination products, other indications and special populations need expansion.
  • Qualified review, personal insomnia/anxiety diagnosis and passionflower, sedative or procedural regimens are not supplied.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.